D Heather Watts

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Combination antiretroviral use and preterm birth
    D Heather Watts
    Pediatric, Adolescent, and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute for Child Health and Human Development, Bethesda, Maryland, USA
    J Infect Dis 207:612-21. 2013
  2. ncbi request reprint The effects of three nonoxynol-9 preparations on vaginal flora and epithelium
    D H Watts
    Pediatric, Adolescent, Maternal AIDS Branch, CRMC NICHD NIH, Bethesda, MD 20892, USA
    J Infect Dis 180:426-37. 1999
  3. ncbi request reprint Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women
    D Heather Watts
    National Institute of Child Health and Human Development, NIH, Bethesda, Maryland 20892 7510, USA
    J Infect Dis 191:1129-39. 2005
  4. ncbi request reprint Teratogenicity risk of antiretroviral therapy in pregnancy
    D Heather Watts
    Pediatric, Adolescent, and Maternal AIDS Branch, CRMC NICHD NIH, 6100 Executive Boulevard, Room 4B11, Bethesda, MD 20892, USA
    Curr HIV/AIDS Rep 4:135-40. 2007
  5. ncbi request reprint Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy
    D Heather Watts
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, NIH, Bethesda, MD 20892, USA
    Am J Obstet Gynecol 191:985-92. 2004
  6. ncbi request reprint Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316
    D Heather Watts
    National Institute of Child Health and Human Development, Bethesda, MD 20892, USA
    Am J Obstet Gynecol 190:506-16. 2004
  7. pmc Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication
    D Heather Watts
    Eunice Kennedy Shriver National Institute for Child Health and Human Development, Bethesda, MD, USA
    J Perinat Med 39:163-70. 2011
  8. ncbi request reprint Progression of HIV disease among women following delivery
    D Heather Watts
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892, USA
    J Acquir Immune Defic Syndr 33:585-93. 2003
  9. ncbi request reprint Management of human immunodeficiency virus infection in pregnancy
    D Heather Watts
    Pediatric, Adolescent, and Maternal AIDS Branch, Center for Research on Mothers and Children, National Institute of Child Health and Human Development, Bethesda, MD 20892, USA
    N Engl J Med 346:1879-91. 2002
  10. ncbi request reprint Treating HIV during pregnancy: an update on safety issues
    D Heather Watts
    Pediatric, Adolescent, and Maternal AIDS Branch, Center for Research for Mothers and Children, National Institute of Child Health and Human Development, Rockville, Maryland, USA
    Drug Saf 29:467-90. 2006

Detail Information

Publications55

  1. pmc Combination antiretroviral use and preterm birth
    D Heather Watts
    Pediatric, Adolescent, and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute for Child Health and Human Development, Bethesda, Maryland, USA
    J Infect Dis 207:612-21. 2013
    ..Use of antiretroviral drugs (ARVs) during pregnancy has been associated with higher risk of preterm birth...
  2. ncbi request reprint The effects of three nonoxynol-9 preparations on vaginal flora and epithelium
    D H Watts
    Pediatric, Adolescent, Maternal AIDS Branch, CRMC NICHD NIH, Bethesda, MD 20892, USA
    J Infect Dis 180:426-37. 1999
    ..Symptoms and colposcopic abnormalities were rare. Changes in levels of vaginal bacteria were transient after single applications of N-9, but adverse effects may be enhanced with frequent, chronic use...
  3. ncbi request reprint Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women
    D Heather Watts
    National Institute of Child Health and Human Development, NIH, Bethesda, Maryland 20892 7510, USA
    J Infect Dis 191:1129-39. 2005
    ..Whether the natural history of human papillomavirus (HPV) infection is affected by bacterial vaginosis (BV) or Trichomonas vaginalis (TV) infection has not been adequately investigated in prospective studies...
  4. ncbi request reprint Teratogenicity risk of antiretroviral therapy in pregnancy
    D Heather Watts
    Pediatric, Adolescent, and Maternal AIDS Branch, CRMC NICHD NIH, 6100 Executive Boulevard, Room 4B11, Bethesda, MD 20892, USA
    Curr HIV/AIDS Rep 4:135-40. 2007
    ..Additional data on risks of antiretrovirals during pregnancy are needed. Providers should report cases of antiretroviral drug exposures during pregnancy to the Antiretroviral Pregnancy Registry...
  5. ncbi request reprint Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy
    D Heather Watts
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, NIH, Bethesda, MD 20892, USA
    Am J Obstet Gynecol 191:985-92. 2004
    ..The purpose of this study was to examine teratogenic risk of antiretroviral (ARV) drugs...
  6. ncbi request reprint Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316
    D Heather Watts
    National Institute of Child Health and Human Development, Bethesda, MD 20892, USA
    Am J Obstet Gynecol 190:506-16. 2004
    ..The purpose of this study was to evaluate rates of maternal toxicity, pregnancy complications, and peripartum morbidity by type and duration of antiretroviral therapy (ART) during pregnancy...
  7. pmc Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication
    D Heather Watts
    Eunice Kennedy Shriver National Institute for Child Health and Human Development, Bethesda, MD, USA
    J Perinat Med 39:163-70. 2011
    ..To determine rate of and risk factors for birth defects in infants born to HIV-infected women receiving nucleoside and protease inhibitor antiretroviral (ARV) therapy...
  8. ncbi request reprint Progression of HIV disease among women following delivery
    D Heather Watts
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892, USA
    J Acquir Immune Defic Syndr 33:585-93. 2003
    ..To assess patterns of HIV disease progression among HIV-1-infected women following delivery...
  9. ncbi request reprint Management of human immunodeficiency virus infection in pregnancy
    D Heather Watts
    Pediatric, Adolescent, and Maternal AIDS Branch, Center for Research on Mothers and Children, National Institute of Child Health and Human Development, Bethesda, MD 20892, USA
    N Engl J Med 346:1879-91. 2002
  10. ncbi request reprint Treating HIV during pregnancy: an update on safety issues
    D Heather Watts
    Pediatric, Adolescent, and Maternal AIDS Branch, Center for Research for Mothers and Children, National Institute of Child Health and Human Development, Rockville, Maryland, USA
    Drug Saf 29:467-90. 2006
    ..Concern has been raised, however, that these exposures may lead to persistent mitochondrial dysfunction or later cancers, underscoring the need for long-term surveillance of antiretroviral-exposed, HIV-uninfected infants...
  11. ncbi request reprint The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: longitudinal findings of the women's interagency HIV study
    D Heather Watts
    Pediatric, Adolescent, and Maternal AIDS Branch, Center for Research on Mothers and Children, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA
    J Acquir Immune Defic Syndr 43:161-8. 2006
    ..To evaluate changes over time in rates of bacterial vaginosis (BV), trichomoniasis (TV), and yeast vaginitis (YV) among HIV-infected and similar HIV-uninfected women...
  12. pmc Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093
    D Heather Watts
    National Institute of Child Health and Human Development, NIH, Bethesda, MD 20892, USA
    Contraception 77:84-90. 2008
    ..We evaluated the safety and tolerability of depot medroxyprogesterone acetate (DMPA) among women on ARV...
  13. ncbi request reprint Assessment of birth defects according to maternal therapy among infants in the Women and Infants Transmission Study
    D Heather Watts
    Pediatric, Adolescent, and Maternal AIDS Branch, Center for Research on Mothers and Infants, National Institute of Child Health and Human Development NIH, 6100 Executive Boulevard, Bethesda, MD 20892, USA
    J Acquir Immune Defic Syndr 44:299-305. 2007
    ..To evaluate rate and types of birth defects according to timing of antiretroviral exposure among babies born to HIV-infected women...
  14. pmc HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial
    D Heather Watts
    Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD Fred Hutchinson Cancer Research Center, Seattle, WA Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA University of Zimbabwe College of Medicine, Harare, Zimbabwe Centre for the AIDS Programme of Research in South Africa CAPRISA, Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa Makerere University Johns Hopkins University Research Collaboration, Kampala, Uganda Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania Harvard School of Public Health, Boston, MA Family Health International, Research Triangle Park, Chapel Hill, NC Johns Hopkins Medical Institutes, Baltimore, MD National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD Maternal Adolescent and Child Health, University of the Witwatersrand, Johannesburg, South Africa, and Statistical Center for HIV AIDS Research and Prevention SCHARP, Seattle, WA
    J Acquir Immune Defic Syndr 64:299-306. 2013
    ..We evaluated disease progression among HIV-infected women not on ART with CD4⁺ lymphocyte counts above 200 cells per microliter at delivery...
  15. pmc Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants
    George K Siberry
    Pediatric Adolescent Maternal AIDS Branch, Eunice Kennedy Shriver National Institutes of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA
    AIDS 26:1151-9. 2012
    ..To evaluate the association of tenofovir disoproxil fumarate (TDF) use during pregnancy with early growth parameters in HIV-exposed, uninfected (HEU) infants...
  16. ncbi request reprint Effect of pregnancy
    D Heather Watts
    National Institute of Child Health and Human Development, National Institutes of Health, DHHS, USA
    J Acquir Immune Defic Syndr 38:S36-8. 2005
  17. ncbi request reprint Changing trends in clinical AIDS presentations and survival among HIV-1-infected women
    Manhattan Charurat
    Division of Epidemiology and Prevention, Institute of Human Virology, University of Maryland, Baltimore, MD, USA
    J Womens Health (Larchmt) 13:719-30. 2004
    ..To profile trends of clinical AIDS-defining illness (ADI) among a cohort of human immunodeficiency virus (HIV)-infected women over a 12-year period...
  18. ncbi request reprint Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084
    Jane Hitti
    University of Washington, Seattle, WA, USA
    Am J Obstet Gynecol 196:331.e1-7. 2007
    ..The objective of the study was to determine whether protease inhibitors increase glucose intolerance and insulin resistance in pregnancy...
  19. pmc Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women
    Jashvant D Unadkat
    Department of Pharmaceutics, University of Washington, Box 357610, Seattle, WA 98195, USA
    Antimicrob Agents Chemother 51:783-6. 2007
    ..Indinavir area under the plasma concentration-time curve was 68% lower antepartum versus postpartum, suggesting increased intestinal and/or hepatic CYP3A activity during pregnancy...
  20. ncbi request reprint Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois University School of Medicine, Springfield, IL 62794 9640, USA
    J Low Genit Tract Dis 11:90-7. 2007
    ..To describe outcomes after treatment of cervical intraepithelial neoplasia (CIN) in women with HIV...
  21. ncbi request reprint Relationship of pregnancy to human papillomavirus among human immunodeficiency virus-infected women
    Howard Minkoff
    Department of Obstetrics and Gynecology, Maimonides Medical Center and SUNY Downstate, Brooklyn, New York, USA
    Obstet Gynecol 108:953-60. 2006
    ....
  22. pmc Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants
    Carmen D Zorrilla
    Obstetrics and Gynecology Department, UPR School of Medicine, P O Box 365067, San Juan, Puerto Rico
    Antimicrob Agents Chemother 51:2208-10. 2007
    ..Two had elevated liver transaminases and amylase. Seven infant adverse events were possibly treatment related (anemia, neutropenia, and hyperbilirubinemia)...
  23. pmc Reproductive health of adolescent girls perinatally infected with HIV
    Susan B Brogly
    Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Mass 02115 6017, USA
    Am J Public Health 97:1047-52. 2007
    ..We sought to describe the reproductive health of adolescent girls perinatally infected with HIV...
  24. pmc Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA
    Marie Louise Newell
    Centre of Paediatric Epidemiology and Biostatistics, Institute of Child Health, University College London, UK
    BMC Infect Dis 7:60. 2007
    ....
  25. ncbi request reprint Contraceptive use among U.S. women with HIV
    L Stewart Massad
    Southern Illinois University School of Medicine, Springfield, Illinois 62794 9640, USA
    J Womens Health (Larchmt) 16:657-66. 2007
    ..To describe trends in and correlates of use of contraception and sterilization among women with the human immunodeficiency virus (HIV)...
  26. ncbi request reprint Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women
    Tiffany G Harris
    Albert Einstein College of Medicine, Bronx, New York 10461, USA
    AIDS 21:1933-41. 2007
    ..This study assessed the relationship of anergy test results with cervical infection by human papillomavirus (HPV) and cervical neoplasia in HIV-seropositive and seronegative women...
  27. ncbi request reprint Analysis of standard methods for diagnosing vaginitis: HIV infection does not complicate the diagnosis of vaginitis
    Beverly E Sha
    Department of Medicine, Section of Infectious Diseases, Rush University Medical Center, Chicago, IL, USA
    J Low Genit Tract Dis 11:240-50. 2007
    ..We sought to determine whether the standard diagnostic methods for vaginitis behave similarly among HIV-infected and at-risk seronegative women...
  28. doi request reprint No association between antepartum serologic and genital tract evidence of herpes simplex virus-2 coinfection and perinatal HIV-1 transmission
    Katherine T Chen
    Department of Obstetrics and Gynecology and Epidemiology, Columbia University, New York, NY 10032, USA
    Am J Obstet Gynecol 198:399.e1-5. 2008
    ..The purpose of this study was to assess the risk of perinatal HIV-1 transmission in women who are coinfected with herpes simplex virus-2 (HSV-2)...
  29. ncbi request reprint Nevirapine concentrations in newborns receiving an extended prophylactic regimen
    Mark Mirochnick
    Department of Pediatrics, Boston University School of Medicine, Boston, MA 02118, USA
    J Acquir Immune Defic Syndr 47:334-7. 2008
    ..The optimal neonatal antiretroviral (ARV) regimen for prevention of HIV mother-to-child transmission (MTCT) is unknown for infants born to mothers who receive no ARVs during pregnancy...
  30. pmc The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women
    Howard Minkoff
    Department of Obstetrics and Gynecology at Maimonides Medical Center and SUNY Downstate, NY 11219, USA
    Infect Dis Obstet Gynecol 2008:587082. 2008
    ..Since both cocaine use and HPV infection are common among HIV-positive women, we sought to determine whether use of cocaine and/or crack influences the natural history of HPV among women with or at high risk of HIV...
  31. ncbi request reprint HIV type 1 zidovudine (ZDV) resistance in blood and uterine cervical secretions of pregnant women
    Lisa M Frenkel
    University of Washington, Seattle, Washington 98109, Children s Hospital and Medical Center of Seattle, Seattle, Washington 98105, USA
    AIDS Res Hum Retroviruses 22:870-3. 2006
    ..However, in only 1 (1.8%) of 57 pregnancies evaluated was resistant virus limited to the cervical secretions. ZDV-resistant virus is rarely limited to the female genital tract...
  32. ncbi request reprint The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine
    Francesca T Aweeka
    Drug Research Unit, University of California, San Francisco, California 94143 0622, USA
    AIDS 20:1833-41. 2006
    ..This study evaluated the impact of female sex and contraceptive therapy on zidovudine plasma and intracellular pharmacokinetics and the impact of contraceptive therapy on HIV viral load...
  33. ncbi request reprint Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women
    Lorna E Thorpe
    New York City Department of Health and Mental Hygiene, New York, NY, USA
    J Acquir Immune Defic Syndr 37:1423-30. 2004
    ..65; 95% confidence interval, 1.00-2.72), especially herpes, pulmonary tuberculosis, and recurrent pneumonia. Hard-drug-using women may have a higher risk for nonfatal opportunistic infections...
  34. ncbi request reprint Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study
    Kiros Berhane
    Keck School of Medicine, University of Southern California, Los Angeles, CA 90089 9011, USA
    J Acquir Immune Defic Syndr 37:1245-52. 2004
    ..Anemia is common in HIV-infected individuals and may be associated with decreased survival...
  35. ncbi request reprint The relationship of pregnancy to human immunodeficiency virus disease progression
    Howard Minkoff
    Department of Obstetrics and Gynecology, Maimonides Medical Center and SUNY Downstate, Brooklyn, New York 11219, USA
    Am J Obstet Gynecol 189:552-9. 2003
    ..This study was undertaken to determine the effect of pregnancy on progression of human immunodeficiency virus (HIV) disease...
  36. ncbi request reprint Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022
    Jane Hitti
    University of Washington, Seattle, 98195, USA
    J Acquir Immune Defic Syndr 36:772-6. 2004
    ..To compare the safety of nelfinavir and nevirapine-based antiretroviral treatment in HIV-1-infected pregnant women...
  37. ncbi request reprint Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women
    Howard Minkoff
    Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, New York, USA
    J Infect Dis 189:1821-8. 2004
    ..Among HIV-infected women, smoking is associated with a significantly higher prevalence and incidence of HPV infection. Smoking during HIV infection may alter the natural history of HPV infection and increase the risk of cervical disease...
  38. ncbi request reprint HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois School of Medicine, Springfield, Illinois 62794, USA
    J Womens Health (Larchmt) 13:147-53. 2004
    ....
  39. pmc Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women
    Edward P Acosta
    University of Alabama at Birmingham, Birmingham, Alabama, USA
    Antimicrob Agents Chemother 48:430-6. 2004
    ..These PK results suggest that SQV-RTV at 800/100 mg b.i.d. appears to be a reasonable treatment option for this population...
  40. ncbi request reprint Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women
    Helen E Cejtin
    Department of Obstetrics and Gynecology, Cook County Hospital, Chicago, IL, USA
    AIDS 17:1702-4. 2003
    ..There did not appear to be an association between hormonal contraception use and HIV-1-RNA levels in our study. There was a small increase in CD4 cell counts among hormonal users of doubtful clinical significance...
  41. ncbi request reprint Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332
    Nancy A Wade
    Department of Pediatrics, Children s Hospital at Albany Medical Center, Albany, New York 12208, USA
    J Infect Dis 190:2167-74. 2004
    ..No infants had positive HIV viral diagnostic tests. d4T with or without 3TC is a potential alternative to ZDV for HIV-infected pregnant women...
  42. ncbi request reprint Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy
    Ruth E Tuomala
    Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Boston, MA 02115, USA
    J Acquir Immune Defic Syndr 38:449-73. 2005
    ..3, 95% CI: 0.2-0.7). Benefits of ART continue to outweigh observed risks...
  43. ncbi request reprint Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results
    Tiffany G Harris
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    JAMA 293:1471-6. 2005
    ....
  44. ncbi request reprint Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women
    L Stewart Massad
    Southern Illinois University School of Medicine, Springfield, Illinois 62794 9640, USA
    J Womens Health (Larchmt) 15:591-8. 2006
    ..To describe menstrual abnormalities among women with HIV...
  45. ncbi request reprint Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women
    Nicolas F Schlecht
    Albert Einstein College of Medicine, Department of Epidemiology and Population Health, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    J Gen Virol 86:2709-20. 2005
    ..If non-European variants are more oncogenic, the effect may involve a late stage in cervical tumorigenesis...
  46. ncbi request reprint Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women
    Howard D Strickler
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Ave, Belfer 1308, Bronx, NY 10461, USA
    J Natl Cancer Inst 97:577-86. 2005
    ....
  47. pmc Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study
    Joseph G Feldman
    SUNY Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203, USA
    Am J Public Health 96:1060-5. 2006
    ..We assessed the association of cigarette smoking with the effectiveness of highly active antiretroviral therapy (HAART) among low-income women...
  48. ncbi request reprint A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery
    D Heather Watts
    Department of Obstetrics and Gynecology, University of Washington, Seattle, USA
    Am J Obstet Gynecol 188:836-43. 2003
    ..The purpose of this study was to assess the efficacy of acyclovir in the reduction of herpes simplex virus culture and polymerase chain reaction positivity and cesarean delivery...
  49. doi request reprint Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up
    L Stewart Massad
    Division of Gynecologic Oncology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Obstet Gynecol 111:1388-93. 2008
    ..To estimate the frequency of and trends in abnormal Pap test results in women with human immunodeficiency virus (HIV) and HIV-uninfected women...
  50. ncbi request reprint Hysterectomy among women with HIV: indications and incidence
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois University School of Medicine, Springfield, IL 62794, USA
    J Acquir Immune Defic Syndr 44:566-8. 2007
    ..To describe hysterectomy rates and indications among women with HIV and to compare them with at-risk HIV-seronegative women...
  51. ncbi request reprint Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study
    Alexandra M Levine
    Department of Medicine, Division of Hematology, University of Southern California, Los Angeles, CA 90033, USA
    Arch Intern Med 166:405-10. 2006
    ..Neither the effect of highly active antiretroviral therapy (HAART) on neutrophil counts nor the significance of neutropenia in terms of survival has previously been evaluated...
  52. doi request reprint Insulin-like growth factor axis and oncogenic human papillomavirus natural history
    Tiffany G Harris
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Cancer Epidemiol Biomarkers Prev 17:245-8. 2008
    ..07; 95% CI, 0.01-0.66). These prospective data provide initial evidence that the IGF axis may influence the natural history of oncogenic HPV...
  53. ncbi request reprint Outcome after negative colposcopy among human immunodeficiency virus-infected women with borderline cytologic abnormalities
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois University School of Medicine, Springfield, Illinois 62794 9640, USA
    Obstet Gynecol 106:525-32. 2005
    ..To estimate the risk of and risk factors for progression among human immunodeficiency virus (HIV)-seropositive women with abnormal cervical cytology but negative colposcopy...
  54. ncbi request reprint Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus
    L Stewart Massad
    Department of Obstetrics and Gynecology, Southern Illinois University School of Medicine, Springfield, Illinois 62794 9640, USA
    Obstet Gynecol 104:1077-85. 2004
    ..We sought to estimate rates of progression and regression of grade 1 cervical intraepithelial neoplasia (CIN 1) among women with human immunodeficiency virus (HIV)...
  55. pmc Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection
    Oluwatoyin Falusi
    Cook County Hospital and Rush Medical College, Chicago, IL 60612, USA
    Clin Infect Dis 35:1414-7. 2002
    ..HIV-infected women aged > or =50 years and those born outside of the United States were more likely to have latent Toxoplasma infection, with prevalences of 32% and 41%, respectively...